Effects of S-312, a new calcium antagonist, on the mechanical and electrophysiological responses of isolated cardiovascular preparations.
スポンサーリンク
概要
- 論文の詳細を見る
S-312, a new calcium antagonist with a bicyclic dihydrothienopyridine structure, potently relaxed the helical strips of various isolated rabbit arteries precontracted with high K<SUP>+</SUP>-depolarization, serotonin (5-HT) and U46619 (thromboxane A<SUB>2</SUB> analogue), and it competitively inhibited Ca<SUP>++</SUP>-induced contractions in depolarized basilar and femoral arteries. These effects of S-312 were more potent than nifedipine and almost comparable to or slightly more potent than those of nicardipine. In comparison with nifedipine and nicardipine, the calcium antagonistic effect and the relaxant effect on 5-HT-induced contractions of S-312 were most prominent in the basilar artery. The potent vasodilating action of S-312 in the high K<SUP>+</SUP>-depolarized basilar artery was not easily reversed by washing. S-312 did not affect Ca<SUP>++</SUP>-Induced contraction in the skinned fiber of guinea pig taenia caecum. The negative inotropic effect of S-312 in isolated guinea pig left atria was much less potent than those of nifedipine and nicardipine. S-312 above 10<SUP>-7</SUP> M preferentially increased AV nodal conduction time in Langendorff-perfused isolated rabbit hearts; and above 3×10<SUP>-8</SUP> M, it mainly decreased the maximum upstroke velocity of the action potential in isolated rabbit sinus node preparations. In summary, the present results indicate that S-312 is a potent new calcium antagonist possessing vasculoselectivity, especially for cerebral vessels.
- 公益社団法人 日本薬理学会の論文
著者
-
Nakajima Shigeyuki
Shionogi Research Laboratories Shionogi & Co. Ltd.
-
Ueda Motohiko
Shionogi Research Laboratories Shionogi & Co. Ltd.
-
TANI Tomoko
Shionogi Research Laboratories, Shionogi & Co., Ltd.
-
NINOMIYA Mitsuyoshi
Shionogi Research Laboratories, Shionogi & Co., Ltd.
関連論文
- Synthesis and Evaluation of Novel Pyrazolo[1,5-a]pyrimidine Derivatives as Nonpeptide Angiotensin II Receptor Antagonists
- Studies on Heart. XIX. Isolation of an Atrial Peptide that improves the Rhythmicity of Cultured Myocardial Cell Clusters
- Neuropeptide YY1 Receptors-Mediated Increase in Intracellular Ca_ Concetration via Phospholipase C-Dependent Pathway in Porcine Aortic Smooth Muscle Cells
- SYNTHESIS AND BIOLOGICAL ACTIVITY OF A NOVEL THROMBOXANE RECEPTOR ANTAGONIST, S-145,AND RELATED DERIVATIVES
- Synthesis and Structure-Activity Relationship of a New Series of Potent Angiotensin II Receptor Antagonists : Pyrazolo[1,5-α]pyrimidine Derivatives
- Effects of Oxytocin on Beating Properties, Myosin ATPase Activity and Macromolecular Synthesis of Rat Myocardial Cells in Culture
- Studies on Heart. XVIII. : Heart Component Influencing the Maintenances of Spreading and Beating of Rat Myocardial Cells in Serum-free Culture
- QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIPS IN 1,2-BENZISOXAZOLYLOXY-PROPANOLAMINE β-ADRENERGIC BLOCKING AGENTS
- INHIBITORY EFFECT OF TRICHLORMETHIAZIDE ON DEVELOPMENT OF DOC HYPERTENSION IN RATS
- Effects of Dilevalol on Adrenoceptors in Isolated Cat Arteries
- SIMILARITIES IN RELAXING EFFECTS BY PHOTOACTIVATED NaNO_2 AND ENDOTHELIUM DERIVED RELAXING FACTOR (EDRF)
- ANTIARRHYTHMIC EFFECT OF APRINDINE ON SEVERAL TYPES OF VENTRICULAR ARRHYTHMIAS
- ANTIHYPERTENSIVE EFFECT OF TRICHLORMETHIAZIDE IN SPONTANEOUSLY HYPERTENSIVE RATS
- Studies of Cardiovascular Responses to Some Endogenous Pressor and Hypotensive Agents in Conscious Stroke-Prone Spontaneously Hypertensive Rats of Different Ages.
- Studies on cardiovascular responses to pressor and hypotensive agents in conscious SHRSP at several ages
- Effects of S-1389 (711389-S), a new antiarrhythmic agent, on the conduction in perfused guinea pig hearts.
- Antihypertensive and Prophylactic Effects of Lisinopril on the Incidences of Cerebral Stroke in SHRSP
- Effects of S-312, a new calcium antagonist, on the mechanical and electrophysiological responses of isolated cardiovascular preparations.